Biotech

All Articles

Former Seagen CEO introduces brand new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2015 for a monstro...

Ironwood produces additional purpose $1B GI medication with new subgroup records

.On the heels of a phase 3 succeed that neglected to blow away investors, Ironwood Pharmaceuticals i...

Novartis inks $150M deal for autoimmune molecular glue

.Do not cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizi...

Jade carves out director team along with Chinook vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of considerable management hirings, firings...

Septerna goes public along with upsized offering of $288M

.Commemorating his firm's upsized going public (IPO), Septerna chief executive officer Jeffrey Finer...

AbbVie makes Richter wealthier, paying $25M to create discovery pact

.AbbVie has actually returned to the source of its own antipsychotic giant Vraylar in search of anot...

GenSight enters into last full weeks of money runway as revenue flow slips by of grasp

.GenSight Biologics is full weeks far from lacking cash. Once again. The biotech just possesses adeq...

AZ licenses disposed of rare condition drug to Monopar Therapeutics

.Monopar Rehabs is recouping a drug coming from the dump of AstraZeneca's rare disease pipe. It has ...

Arcus' new HIF-2a data in renal cancer hint at prospective edge over Merck's Welireg, experts say

.With new information out on Arcus Biosciences' speculative HIF-2a prevention, one group of experts ...

Roche wagers as much as $1B to extend Dyno genetics therapy delivery contract

.After forming a genetics treatment collaboration with Dyno Rehabs in 2020, Roche is actually back f...